These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32006750)

  • 1. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kim S; Lee DW; Jin JS; Kim J
    J Glob Antimicrob Resist; 2020 Sep; 22():32-39. PubMed ID: 32006750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
    Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
    Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
    Kim S; Jin JS; Choi YJ; Kim J
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens.
    Euler CW; Raz A; Hernandez A; Serrano A; Xu S; Andersson M; Zou G; Zhang Y; Fischetti VA; Li J
    Antimicrob Agents Chemother; 2023 May; 67(5):e0151922. PubMed ID: 37098944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii.
    Sitthisak S; Manrueang S; Khongfak S; Leungtongkam U; Thummeepak R; Thanwisai A; Burton N; Dhanoa GK; Tsapras P; Sagona AP
    Sci Rep; 2023 May; 13(1):7470. PubMed ID: 37156803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens.
    Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M
    J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens.
    Basit A; Qadir S; Qureshi S; Rehman SU
    Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.
    Peng SY; You RI; Lai MJ; Lin NT; Chen LK; Chang KC
    Sci Rep; 2017 Sep; 7(1):11477. PubMed ID: 28904355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against
    Wu M; Hu K; Xie Y; Liu Y; Mu D; Guo H; Zhang Z; Zhang Y; Chang D; Shi Y
    Front Microbiol; 2018; 9():3302. PubMed ID: 30687281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin.
    Lim J; Jang J; Myung H; Song M
    J Microbiol; 2022 Aug; 60(8):859-866. PubMed ID: 35614377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Antimicrobial Endolysin, LysPA26, against
    Guo M; Feng C; Ren J; Zhuang X; Zhang Y; Zhu Y; Dong K; He P; Guo X; Qin J
    Front Microbiol; 2017; 8():293. PubMed ID: 28289407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen
    Deng S; Xu Q; Fu Y; Liang L; Wu Y; Peng F; Gao M
    Viruses; 2021 May; 13(6):. PubMed ID: 34072620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus.
    Saito H; Sakakibara Y; Sakata A; Kurashige R; Murakami D; Kageshima H; Saito A; Miyazaki Y
    PLoS One; 2019; 14(5):e0217504. PubMed ID: 31136634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial peptide thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model.
    Lim J; Myung H; Lim D; Song M
    J Biomed Sci; 2024 Apr; 31(1):36. PubMed ID: 38622637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel bacteriophage endolysin (LysAB1245) with extended lytic activity against distinct capsular types associated with Acinetobacter baumannii resistance.
    Soontarach R; Srimanote P; Arechanajan B; Nakkaew A; Voravuthikunchai SP; Chusri S
    PLoS One; 2024; 19(1):e0296453. PubMed ID: 38165983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
    Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
    BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ts2631 Endolysin from the Extremophilic
    Plotka M; Kapusta M; Dorawa S; Kaczorowska AK; Kaczorowski T
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.